» Articles » PMID: 39164792

Targeting Mitochondrial Quality Control: New Therapeutic Strategies for Major Diseases

Overview
Journal Mil Med Res
Publisher Biomed Central
Specialty Emergency Medicine
Date 2024 Aug 20
PMID 39164792
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria play a crucial role in maintaining the normal physiological state of cells. Hence, ensuring mitochondrial quality control is imperative for the prevention and treatment of numerous diseases. Previous reviews on this topic have however been inconsistencies and lack of systematic organization. Therefore, this review aims to provide a comprehensive and systematic overview of mitochondrial quality control and explore the possibility of targeting the same for the treatment of major diseases. This review systematically summarizes three fundamental characteristics of mitochondrial quality control, including mitochondrial morphology and dynamics, function and metabolism, and protein expression and regulation. It also extensively examines how imbalances in mitochondrial quality are linked to major diseases, such as ischemia-hypoxia, inflammatory disorders, viral infections, metabolic dysregulations, degenerative conditions, and tumors. Additionally, the review explores innovative approaches to target mitochondrial quality control, including using small molecule drugs that regulate critical steps in maintaining mitochondrial quality, nanomolecular materials designed for precise targeting of mitochondria, and novel cellular therapies, such as vesicle therapy and mitochondrial transplantation. This review offers a novel perspective on comprehending the shared mechanisms underlying the occurrence and progression of major diseases and provides theoretical support and practical guidance for the clinical implementation of innovative therapeutic strategies that target mitochondrial quality control for treating major diseases.

Citing Articles

Lysosome-Mitochondrial Crosstalk in Cellular Stress and Disease.

Kiraly S, Stanley J, Eden E Antioxidants (Basel). 2025; 14(2).

PMID: 40002312 PMC: 11852311. DOI: 10.3390/antiox14020125.


A rhodamine-coordinated iridium complex to overcome cisplatin-resistant cancer via regulating mitochondrial function triggered apoptosis and ferroptosis.

Li J, Gao G, Ouyang W, Huang J, Liu H, Li J Redox Biol. 2025; 81:103536.

PMID: 39956024 PMC: 11872635. DOI: 10.1016/j.redox.2025.103536.


Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms.

Anchimowicz J, Zielonka P, Jakiela S Int J Mol Sci. 2025; 26(1.

PMID: 39796234 PMC: 11720160. DOI: 10.3390/ijms26010380.


The multifaceted role of mitochondria in cardiac function: insights and approaches.

Ravindran S, Rau C Cell Commun Signal. 2024; 22(1):525.

PMID: 39472951 PMC: 11523909. DOI: 10.1186/s12964-024-01899-x.


Exploring the Mechanism of Ferroptosis Induction by Sappanone A in Cancer: Insights into the Mitochondrial Dysfunction Mediated by NRF2/xCT/GPX4 Axis.

Wang J, Zhuang H, Yang X, Guo Z, Zhou K, Liu N Int J Biol Sci. 2024; 20(13):5145-5161.

PMID: 39430236 PMC: 11488586. DOI: 10.7150/ijbs.96748.

References
1.
Mehrzadi S, Karimi M, Fatemi A, Reiter R, Hosseinzadeh A . SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin. Pharmacol Ther. 2021; 224:107825. PMC: 7919585. DOI: 10.1016/j.pharmthera.2021.107825. View

2.
Fields M, Marcuzzi A, Gonelli A, Celeghini C, Maximova N, Rimondi E . Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations. Int J Mol Sci. 2023; 24(4). PMC: 9960436. DOI: 10.3390/ijms24043739. View

3.
Ong S, Subrayan S, Lim S, Yellon D, Davidson S, Hausenloy D . Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation. 2010; 121(18):2012-22. DOI: 10.1161/CIRCULATIONAHA.109.906610. View

4.
Li P, Chen T, Kuang P, Liu F, Li Z, Liu F . Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality. Cell Death Dis. 2022; 13(7):606. PMC: 9279325. DOI: 10.1038/s41419-022-04973-9. View

5.
Alberici L, Oliveira H . Mitochondrial Adaptive Responses to Hypertriglyceridemia and Bioactive Lipids. Antioxid Redox Signal. 2021; 36(13-15):953-968. DOI: 10.1089/ars.2021.0180. View